Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079303 | SCV000111173 | benign | not specified | 2013-02-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000079303 | SCV000917102 | benign | not specified | 2018-01-12 | criteria provided, single submitter | clinical testing | Variant summary: The CACNA1C c.5680+11C>T variant involves the alteration of a non-conserved intronic nucleotide and 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 134/30490 control chromosomes (gnomAD), predominantly observed in the African subpopulation at a frequency of 0.007961 (68/8542). This frequency is about 796 times the estimated maximal expected allele frequency of a pathogenic CACNA1C variant (0.00001), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. In addition, multiple clinical diagnostic laboratories classified this variant as "likely benign/benign." The variant of interest has not, to our knowledge, been reported in affected individuals via publications. Taken together, this variant is classified as benign. |
ARUP Laboratories, |
RCV001610358 | SCV001159688 | benign | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610358 | SCV001837852 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002055108 | SCV002468639 | benign | Long QT syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001610358 | SCV005234742 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000079303 | SCV001932379 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000079303 | SCV001959847 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000079303 | SCV001978791 | benign | not specified | no assertion criteria provided | clinical testing |